INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 111 filers reported holding INSMED INC in Q1 2014. The put-call ratio across all filers is 0.75 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,570,293 | +27.2% | 2,873,697 | +6.3% | 0.01% | +28.6% |
| Q2 2023 | $57,044,777 | +27.4% | 2,703,543 | +3.0% | 0.01% | +16.7% |
| Q1 2023 | $44,767,776 | +89656.4% | 2,625,675 | +5.2% | 0.01% | -14.3% |
| Q4 2022 | $49,877 | -99.9% | 2,496,389 | +16.4% | 0.01% | 0.0% |
| Q3 2022 | $46,187,000 | +11.7% | 2,144,283 | +2.3% | 0.01% | +16.7% |
| Q2 2022 | $41,350,000 | -16.9% | 2,096,868 | -1.0% | 0.01% | 0.0% |
| Q1 2022 | $49,781,000 | -11.2% | 2,118,354 | +2.9% | 0.01% | -14.3% |
| Q4 2021 | $56,059,000 | +1.3% | 2,057,992 | +2.5% | 0.01% | 0.0% |
| Q3 2021 | $55,314,000 | +2.4% | 2,008,497 | +5.8% | 0.01% | 0.0% |
| Q2 2021 | $54,037,000 | -7.9% | 1,898,730 | +10.2% | 0.01% | -22.2% |
| Q1 2021 | $58,699,000 | +10.4% | 1,723,414 | +7.9% | 0.01% | 0.0% |
| Q4 2020 | $53,151,000 | +9.4% | 1,596,632 | +5.7% | 0.01% | -10.0% |
| Q3 2020 | $48,571,000 | +15.1% | 1,511,238 | -1.4% | 0.01% | +11.1% |
| Q2 2020 | $42,201,000 | +97.9% | 1,532,359 | +15.2% | 0.01% | +50.0% |
| Q1 2020 | $21,322,000 | -63.3% | 1,330,184 | -45.3% | 0.01% | 0.0% |
| Q4 2019 | $58,038,000 | +181.6% | 2,430,422 | +108.0% | 0.01% | +20.0% |
| Q3 2019 | $20,608,000 | -26.9% | 1,168,296 | +6.1% | 0.01% | -28.6% |
| Q2 2019 | $28,200,000 | +1.3% | 1,101,569 | +15.0% | 0.01% | 0.0% |
| Q1 2019 | $27,836,000 | +22.4% | 957,552 | -44.7% | 0.01% | +75.0% |
| Q4 2018 | $22,736,000 | +38.6% | 1,732,978 | +113.6% | 0.00% | -20.0% |
| Q3 2018 | $16,407,000 | -10.2% | 811,463 | +5.0% | 0.01% | -16.7% |
| Q2 2018 | $18,280,000 | +11.0% | 772,956 | +5.7% | 0.01% | +20.0% |
| Q1 2018 | $16,467,000 | -23.7% | 731,229 | +5.7% | 0.01% | -28.6% |
| Q4 2017 | $21,575,000 | +2.8% | 691,982 | +2.9% | 0.01% | -12.5% |
| Q3 2017 | $20,980,000 | +130.2% | 672,272 | +26.6% | 0.01% | +100.0% |
| Q2 2017 | $9,114,000 | +5.5% | 531,151 | +7.7% | 0.00% | 0.0% |
| Q1 2017 | $8,635,000 | +38.6% | 493,181 | +4.7% | 0.00% | +33.3% |
| Q4 2016 | $6,229,000 | -5.5% | 470,836 | +3.7% | 0.00% | 0.0% |
| Q3 2016 | $6,592,000 | +48.4% | 454,018 | +0.8% | 0.00% | +50.0% |
| Q2 2016 | $4,441,000 | -17.5% | 450,499 | +6.0% | 0.00% | -33.3% |
| Q1 2016 | $5,382,000 | -27.2% | 424,851 | +4.3% | 0.00% | -25.0% |
| Q4 2015 | $7,389,000 | -1.6% | 407,143 | +0.7% | 0.00% | -20.0% |
| Q3 2015 | $7,510,000 | -23.5% | 404,416 | +0.6% | 0.01% | -16.7% |
| Q2 2015 | $9,819,000 | +64.1% | 402,122 | +39.8% | 0.01% | +100.0% |
| Q1 2015 | $5,982,000 | +47.7% | 287,619 | +9.8% | 0.00% | +50.0% |
| Q4 2014 | $4,050,000 | +20.9% | 261,860 | +2.0% | 0.00% | 0.0% |
| Q3 2014 | $3,350,000 | -4.4% | 256,761 | +46.3% | 0.00% | 0.0% |
| Q2 2014 | $3,506,000 | +7.5% | 175,495 | +2.5% | 0.00% | 0.0% |
| Q1 2014 | $3,260,000 | +15.0% | 171,223 | +2.7% | 0.00% | 0.0% |
| Q4 2013 | $2,835,000 | +10.9% | 166,668 | +1.8% | 0.00% | 0.0% |
| Q3 2013 | $2,556,000 | +57.2% | 163,744 | +20.5% | 0.00% | +100.0% |
| Q2 2013 | $1,626,000 | – | 135,915 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 5,054,713 | $49,839,000 | 3.76% |
| SENZAR ASSET MANAGEMENT, LLC | 788,936 | $7,778,909,000 | 1.70% |
| NEXTHERA CAPITAL LP | 168,700 | $1,663,000 | 1.44% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $2,169,000 | 1.04% |
| Orbimed Advisors | 4,158,600 | $41,004,000 | 0.43% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 667,848 | $6,585,000 | 0.37% |
| Rock Springs Capital Management LP | 497,500 | $4,905,000 | 0.36% |
| EMERALD ADVISERS, LLC | 630,159 | $6,213,000 | 0.30% |
| Virtus ETF Advisers LLC | 24,536 | $242,000 | 0.18% |
| Baker Brothers Advisors | 1,500,000 | $14,790,000 | 0.16% |